Cargando…

Covid-19, nervous system pathology, and Parkinson's disease: Bench to bedside

Coronavirus disease 2019 (Covid-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection is primarily regarded as a respiratory disease; however, multisystemic involvement accompanied by a variety of clinical manifestations, including neurological symptoms, are commonly o...

Descripción completa

Detalles Bibliográficos
Autores principales: Emmi, Aron, Boura, Iro, Raeder, Vanessa, Mathew, Donna, Sulzer, David, Goldman, James E., Leta, Valentina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361071/
https://www.ncbi.nlm.nih.gov/pubmed/36208899
http://dx.doi.org/10.1016/bs.irn.2022.06.006
_version_ 1784764452033265664
author Emmi, Aron
Boura, Iro
Raeder, Vanessa
Mathew, Donna
Sulzer, David
Goldman, James E.
Leta, Valentina
author_facet Emmi, Aron
Boura, Iro
Raeder, Vanessa
Mathew, Donna
Sulzer, David
Goldman, James E.
Leta, Valentina
author_sort Emmi, Aron
collection PubMed
description Coronavirus disease 2019 (Covid-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection is primarily regarded as a respiratory disease; however, multisystemic involvement accompanied by a variety of clinical manifestations, including neurological symptoms, are commonly observed. There is, however, little evidence supporting SARS-CoV-2 infection of central nervous system cells, and neurological symptoms for the most part appear to be due to damage mediated by hypoxic/ischemic and/or inflammatory insults. In this chapter, we report evidence on candidate neuropathological mechanisms underlying neurological manifestations in Covid-19, suggesting that while there is mostly evidence against SARS-CoV-2 entry into brain parenchymal cells as a mechanism that may trigger Parkinson's disease and parkinsonism, that there are multiple means by which the virus may cause neurological symptoms.
format Online
Article
Text
id pubmed-9361071
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-93610712022-08-09 Covid-19, nervous system pathology, and Parkinson's disease: Bench to bedside Emmi, Aron Boura, Iro Raeder, Vanessa Mathew, Donna Sulzer, David Goldman, James E. Leta, Valentina Int Rev Neurobiol Article Coronavirus disease 2019 (Covid-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection is primarily regarded as a respiratory disease; however, multisystemic involvement accompanied by a variety of clinical manifestations, including neurological symptoms, are commonly observed. There is, however, little evidence supporting SARS-CoV-2 infection of central nervous system cells, and neurological symptoms for the most part appear to be due to damage mediated by hypoxic/ischemic and/or inflammatory insults. In this chapter, we report evidence on candidate neuropathological mechanisms underlying neurological manifestations in Covid-19, suggesting that while there is mostly evidence against SARS-CoV-2 entry into brain parenchymal cells as a mechanism that may trigger Parkinson's disease and parkinsonism, that there are multiple means by which the virus may cause neurological symptoms. Elsevier Inc. 2022 2022-08-09 /pmc/articles/PMC9361071/ /pubmed/36208899 http://dx.doi.org/10.1016/bs.irn.2022.06.006 Text en Copyright © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Emmi, Aron
Boura, Iro
Raeder, Vanessa
Mathew, Donna
Sulzer, David
Goldman, James E.
Leta, Valentina
Covid-19, nervous system pathology, and Parkinson's disease: Bench to bedside
title Covid-19, nervous system pathology, and Parkinson's disease: Bench to bedside
title_full Covid-19, nervous system pathology, and Parkinson's disease: Bench to bedside
title_fullStr Covid-19, nervous system pathology, and Parkinson's disease: Bench to bedside
title_full_unstemmed Covid-19, nervous system pathology, and Parkinson's disease: Bench to bedside
title_short Covid-19, nervous system pathology, and Parkinson's disease: Bench to bedside
title_sort covid-19, nervous system pathology, and parkinson's disease: bench to bedside
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361071/
https://www.ncbi.nlm.nih.gov/pubmed/36208899
http://dx.doi.org/10.1016/bs.irn.2022.06.006
work_keys_str_mv AT emmiaron covid19nervoussystempathologyandparkinsonsdiseasebenchtobedside
AT bourairo covid19nervoussystempathologyandparkinsonsdiseasebenchtobedside
AT raedervanessa covid19nervoussystempathologyandparkinsonsdiseasebenchtobedside
AT mathewdonna covid19nervoussystempathologyandparkinsonsdiseasebenchtobedside
AT sulzerdavid covid19nervoussystempathologyandparkinsonsdiseasebenchtobedside
AT goldmanjamese covid19nervoussystempathologyandparkinsonsdiseasebenchtobedside
AT letavalentina covid19nervoussystempathologyandparkinsonsdiseasebenchtobedside